The Chemours News

Goldman Sachs Maintains The Chemours(CC.US) With Hold Rating, Cuts Target Price to $23

Moomoo NewsSep 3 12:31 ET

Morgan Stanley Maintains The Chemours(CC.US) With Hold Rating, Maintains Target Price $30

Moomoo NewsAug 6 09:33 ET

Chemours Analyst Ratings

BenzingaAug 6 07:55 ET

BMO Capital Maintains The Chemours(CC.US) With Buy Rating, Cuts Target Price to $30

Moomoo NewsAug 6 07:35 ET

Barclays Maintains The Chemours(CC.US) With Hold Rating, Cuts Target Price to $22

Moomoo NewsAug 6 06:31 ET

Chemours Analyst Ratings

BenzingaJul 9 08:57 ET

UBS Upgrades Chemours to Buy From Neutral, Raises Price Target to $30 From $28

MT NewswiresJul 9 08:18 ET

Chemours Analyst Ratings

BenzingaJun 7 06:41 ET

Barclays Keeps Their Hold Rating on Chemours Company (CC)

TipRanksMay 15 05:35 ET

Chemours Upgraded at BMO Capital After Internal Audit Completed

Seeking AlphaApr 9 07:42 ET

Chemours Analyst Ratings

BenzingaApr 9 05:48 ET

Chemours Analyst Ratings

BenzingaApr 2 14:14 ET

Research Alert: CFRA

MT NewswiresApr 1 14:18 ET

Chemours Analyst Ratings

BenzingaMar 5 06:01 ET

Chemours Analyst Ratings

BenzingaFeb 29 12:36 ET

Chemours Company (CC) Receives a Buy From RBC Capital

TipRanksDec 21, 2023 20:47 ET

Chemours Analyst Ratings

BenzingaDec 1, 2023 04:21 ET

JP Morgan Maintains Neutral on Chemours, Lowers Price Target to $26

BenzingaNov 7, 2023 15:09 ET

Chemours Analyst Ratings

BenzingaNov 7, 2023 15:08 ET

Goldman Sachs Maintains Neutral on Chemours, Lowers Price Target to $30

BenzingaOct 31, 2023 09:41 ET